(Q44225838)

1 December 2017

Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis (English)

1 reference

1 December 2017

1 reference

1 reference

1 reference

1

1 reference

1 December 2017

3

1 reference

1 December 2017

John J Engemann

2

1 reference

1 December 2017

Ellen R Fortenberry

series ordinal

4

1 reference

1 December 2017

Carol D Hamilton

series ordinal

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

21 November 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

1 December 2017

1 reference

1 December 2017

167

1 reference

1 December 2017

6

1 reference

1 December 2017

824-827

1 reference

Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men.

1 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Abstracts of the 2001 Annual IDSA Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-998OC

10.1164/RCCM.200209-998OC

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference